In January, the FDA announced the approval of three of Takeda’s new once-daily DPP-4 inhibitor pills for type 2 diabetes. DPP-4 inhibitors have been the best-selling...

This quick-reading, constructive book will serve you well in devising or refining your diabetes game plan.

Exercise and weight loss have been shown to significantly reduce a person’s risk of moving from prediabetes to type 2 diabetes. However, insurance coverage for these...

Dr. Arya Sharma highlights the most important weight loss tip everyone should know and why weight maintenance is a major achievement.

On November 14, World Diabetes Day was commemorated at 574 blue-lit monuments around the world. The annual event is meant to be a rallying experience for the global...

Gary Scheiner searches for the happy medium between neglecting your diabetes care and being completely overwhelmed.

On December 11, Omada Health launched Prevent Now , an online version of the Diabetes Prevention Program (DPP). The landmark NIH-funded DPP study found that moderate...

(S)he said what!?

Friends for Life, the national Children with Diabetes (CWD) conference, took place in Orlando, Florida, from July 11 to July 15.

On July 13, Johnson & Johnson acquired Calibra Medical , maker of the Finesse “insulin patch-pen” for type 1 and type 2 diabetes. The slimly designed Finesse (2...

(S)he said what!?

The Partnership for a Healthier America (PHA) will hold its second Building a Healthier Future Summit from March 6-8, 2013, in Washington, DC. We cannot wait to hear...

On August 17, the FDA approved Mylan’s new generic versions of Actos (pioglitazone), a once-daily oral tablet for the treatment of type 2 diabetes originally sold by...

Jim Hirsch sheds light on the shocking conditions an inmate with type 1 diabetes is enduring while behind bars. You can help him by signing our petition to protest this...

On World Diabetes Day in San Francisco, Manny Hernandez of the Diabetes Hands Foundation (DHF) announced that the DHF had exceeded its goal to get 20,000 people to take...

Can a drug for type 2 diabetes work for those with type 1? How will a new basal insulin compare to Lantus?

The newest in CGM: learn about Dexcom’s redesigned, more accurate, and sleeker G4 Platinum system.

Amylin Pharmaceuticals, developer of the GLP-1 agonists Byetta and Bydureon ( recently acquired by Bristol-Myers Squibb ), has pledged to donate $5 to a diabetes charity...

James Hirsch assesses the implications for diabetes from the bestseller Salt Sugar Fat .

We like Practical Diabetology because it's straightforward, actionable, and smart — but, be warned, it's for physicians.